Format

Send to

Choose Destination
Best Pract Res Clin Endocrinol Metab. 2011 Apr;25(2):287-302. doi: 10.1016/j.beem.2010.09.007.

Testicular function and fertility preservation in male cancer patients.

Author information

1
Division of Hematology-Oncology and Stem Cell Transplantation, Hospital for Children and Adolescents, University of Helsinki, FIN-00029 Helsinki, Finland. kirsi.jahnukainen@ki.se

Abstract

The testis has been shown to be highly susceptible to the toxic effects of cancer therapy at all stages of life. Young cancer survivors are approximately half as likely as their siblings to sire a pregnancy. Radiation therapy to the testes and high cumulative dose of alkylating agents are the major factors decreasing the probability of fertility. This review aims to present an overview of the current state of knowledge in mechanisms how human spermatogonia proliferate and differentiate and how cancer therapy affects germ cells, what are the options for fertility preservation and what are the clinical risks and limitations related to such procedures. This area of research is discussed in the context of the potential future options that may become available for preserving fertility in male cancer patients.

PMID:
21397199
DOI:
10.1016/j.beem.2010.09.007
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center